Records are supplied by study sponsors and investigators. A registry listing is not an endorsement or a guarantee of safety, availability or eligibility.
WCR feed checked: Nov 12, 2026.
RecruitingNCT07398417
Fibromyalgia
Phase 318 years - Not specifiedGlendale, Arizona, United States +52 The study is a Phase 3, double-blind, placebo-controlled, randomized withdrawal study to assess the efficacy and safety of AXS-14 in the management of fibromyalgia.
Not yet recruitingNCT07767526
Schizophrenia · Antipsychotic Drug
Phase 1 / Phase 218 years - 65 yearsShanghai, China Antipsychotic medications are widely used to treat schizophrenia but may cause constipation, which can lead to abdominal discomfort, reduced quality of life, and poor treatment adherence. Xingqi Daozhi Decoction is a traditional Chinese medicine form…
RecruitingNCT03973268
Depression · Major Depressive Disorder · Major Depression
Phase 118 years - 70 yearsBethesda, Maryland, United States Background: Most drugs that treat mood disorders take a long time to work. Ketamine works within hours. A dose can last for a week or more. Certain receptors in the brain might help ketamine work. A drug that blocks these receptors might affect how i…
RecruitingNCT05416489
Intubated Patients · Percutaneous Tracheostomy
Not applicable18 years - 85 yearsSantiago de Compostela, A Coruña, Spain When preparing an ICU patient for percutaneous dilational tracheostomy, correct positioning of the endotracheal tube is important. During the procedure, it is possible to puncture the cuff. Tracheal tube cuff puncture can lead to failure of ventilati…
RecruitingNCT07929974
EBV Activation and EBV-PTLD After Allogeneic Hematopoietic Stem Cell Transplantation
Phase 2 / Phase 314 years - 70 yearsHefei, Anhui, China +9 The main purpose of this study is to evaluate the preventive effect and safety of CD20 monoclonal antibody clearing B cells on EBV activation 180 days after allogeneic hematopoietic stem cell transplantation. The study will also observe the effects o…
RecruitingNCT06429176
Cystic Fibrosis
Phase 218 years - Not specifiedLong Beach, California, United States +25 The goal of this clinical trial is to learn if drug SPL84 is safe for adult patients with cystic fibrosis (CF). It will also learn if the drug works to treat works to treat CF with a specific mutation (3849 +10kb C--\>T). The purpose of this research…
Active, not recruitingNCT02263014
Breast Cancer
Observational18 years - Not specifiedHouston, Texas, United States The goal of this research study is to learn more about how different treatment decisions may influence the quality of life in women with breast cancer. Researchers want to use what is learned from this study to help future patients with breast cancer…
CompletedNCT07211152
Influenza
Phase 318 years - 39 yearsMandaluyong, National Capital Region, Philippines +1 This is a randomized, double-blind, positive controlled phase Ⅲ clinical trial to assess the immunogenicity and safety of Sinovac QIV in pregnant women. A total of 150 healthy pregnant women aged 18\~39 years at 20 to 32 weeks of pregnancy will be en…
RecruitingNCT05600764
TRPV4 Gene Mutation
Observational3 years - 80 yearsBaltimore, Maryland, United States The goal of this research is to document the natural history of neuropathy in patients with a confirmed genetic mutation in the TRPV4 gene. The investigators are searching for patients willing to participate in a 6-year long study to document the sym…
Active, not recruitingNCT06467344
Stargardt Disease · Cone Rod Dystrophy · Juvenile Macular Degeneration · Stargardt Disease 1
Phase 1 / Phase 212 years - Not specifiedSan Francisco, California, United States +10 This study is an open-label, single ascending dose clinical trial in participants who have ABCA4-related retinopathies. This is the first-in-human clinical trial in which ACDN-01 will be evaluated for safety, tolerability, and preliminary efficacy fo…
RecruitingNCT07430306
Systemic Lupus Erythematosus
Phase 318 years - 70 yearsAnniston, Alabama, United States +88 The purpose of the SUNFLOWER study is to describe clinical outcomes, including DORIS remission, achieved following the initiation of anifrolumab 120 mg SC once weekly (QW) as add-on therapy to an anti-malarial, with or without GC; in patients not in …
Not yet recruitingNCT07927946
SCHIZOPHRENIA 1 (Disorder)
Phase 418 years - 65 yearsOrange, California, United States +2 This is a prospective, multicenter, open-label, single-arm study evaluating ERZOFRI (paliperidone palmitate) 351 mg administered every 4 weeks as maintenance treatment in approximately 40 adults with schizophrenia who experience symptom worsening bef…
Retrieved from ClinicalTrials.gov: Nov 12, 2026. Overall study status may differ from a particular location’s status.
